Core Viewpoint - Alvotech has successfully negotiated a reduction in the interest rate on its senior secured term loan facility, resulting in significant cost savings and reflecting improved financial performance and operational efficiency [1][2][3] Company Overview - Alvotech is a global biotech company focused on developing and manufacturing biosimilar medicines, aiming to be a leader in the biosimilar market by providing high-quality, cost-effective products [4] - The company has launched two biosimilars and has a pipeline of nine disclosed biosimilar candidates targeting various diseases, including autoimmune disorders and cancer [4] Financial Details - The senior secured term loan facility, originally funded in July 2024, has been restructured to lower the interest rate from SOFR plus 6.5% to SOFR plus 6.0%, simplifying the capital structure by consolidating two tranches into one [3] - The estimated reduction in interest payments for the first year is approximately US$8.2 million, contributing to a more favorable financial outlook [1][3] - As of June 25, 2025, the balance of the facility is approximately $1,081 million, with a cash balance of around $152 million [3] Strategic Partnerships - Alvotech has established a network of strategic commercial partnerships across various regions, including the United States, Europe, and Asia, to enhance its market reach and leverage local expertise [4]

Announcement about a change in a major shareholder’s shareholding, cf. S.31 of the Danish Capital Market Act. In continuation of the capital reduction implemented by cancellation of 2,765,118 own shares of a nominal value of DKK 10 as described in Corporate Announcement No. 26 of 12 June 2025, we hereby announce in accordance with S.31 of the Danish Capital Market Act that Jyske Bank A/S as at 12 June 2022 directly and indirectly held 998,572 shares of a nominal value of DKK 10 of Jyske Bank A/S correspond ...

At Jyske Bank A/S' extraordinary general meeting on 24 April 2025, it was finally decided to reduce Jyske Bank's share capital by a nominal value of DKK 27,651,180, corresponding to 2,765,118 shares of a nominal value of DKK 10. The capital reduction takes place through cancellation of own shares and will be spent on payment to shareholders. After expiry of the deadline of the company’s creditors to lodge their claims in the company, cf. S.192(1) of the Danish Companies Act, the company’s Supervisory Board ...

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company"), an emerging growth company engaged in the crypto mining business with diversified expansion strategies, today announced that a court hearing will be held at 10:00 a.m. on June 5, 2025, before the Grand Court of the Cayman Islands to consider the confirmation of its proposed share capital reduction. As previously disclosed on the report on Form 6-K filed with the Securities and Exchange Commission on Mar ...

Company Announcement Copenhagen, 12 May 2025 No. 31/2025 Reduction of share capital ISS A/S (the “Company”), a leading workplace experience and facility management company, today announces that the capital decrease in connection with cancellation of own shares has been completed. Reference is made to the company announcement of 11 April 2025 regarding the annual general meeting’s approval of the decision to decrease the share capital with nominally DKK 11,468,226 from nominally DKK 185,668,226 to nominally ...

Core Points - The Annual General Meeting (AGM) of Norsk Hydro ASA took place on May 9, 2025, where all proposals from the Board of Directors were adopted, including a dividend distribution of NOK 2.25 per share [1] - A capital reduction was resolved through the cancellation of own shares and redemption of shares held by the Norwegian State [1] Dividend Details - The dividend will be paid on May 20, 2025, to shareholders registered as of May 9, 2025, with the shares trading excluding the right to dividend from May 12, 2025 [2] - Shareholder proposals were presented but none were adopted during the meeting [2] Additional Information - The minutes of the AGM are available on the company's website [3] - Contact information for investor and media inquiries is provided [3]

NN (NNBR) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Stephen Poe - Assistant Vice PresidentHarold Bevis - CEO, President & DirectorChristopher H. Bohnert - Senior Vice President and Chief Financial OfficerTim French - SVP & COO Conference Call Participants Rob Brown - Founding Partner & Senior Research AnalystHans Baldau - Equity Research AnalystJohn Franzreb - Senior Equity Analyst Operator Good day, and welcome to the NN Inc. First Quarter twenty twenty five Earnings Conference Ca ...

2025 Q1 Earnings May 8, 2025 Forward Looking Statement & Disclosures Except for specific historical information, many of the matters discussed in this presentation may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These statements may discuss goals, intentions and expectations as to future trends, plans, events, results of operations or financial condition, or state other information relating to ...

Nasdaq CopenhagenEuronext DublinLondon Stock Exchange Other partners Date 5 May 2025 Implementation of capital reduction As advised in the company announcement of 5 March 2025 “Minutes of the annual general meeting held on 5 March 2025”, it was decided at the bank´s annual general meeting to reduce the bank´s share capital by nom. DKK 1,315,042 by cancellation of 1,315,042 own shares. The deadline of the statutory notice to the bank’s creditors has expired with no claims being reported, and final registra ...

At Tryg’s annual general meeting on 26 March 2025, it was decided to cancel repurchased shares from the Group’s share buyback program. The Group’s share capital is reduced by nominal DKK 25,088,935 to nominal DKK 3,056,871,610. The reduction of the share capital was announced by the Danish Business Authority on 28 March 2025. Tryg has not received any objections to the capital reduction. Therefore, the reduction is effective as the Danish Business Authority has registered the capital reduction. After the c ...